Arkolith/Insider Trading/GALT/Form 4

Jamil Khurram

Chief Medical OfficerGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed May 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 26, 2026Option exercise(M)568$1.23$699568
May 26, 2026Sell(S)568$3.10$2K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 26, 2026Option exercise(M)568—$040K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000055) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML